uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.
View Top Employees from uniQureWebsite | http://www.uniqure.com/ |
Ticker | NASDAQ:QURE |
Employees | 612 (612 on RocketReach) |
Founded | 1998 |
Address | Paasheuvelweg 25a, Amsterdam, North Holland 1105BP, NL |
Phone | +31 20 566 7394 |
Technologies |
JavaScript,
HTML,
PHP
+48 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Holding Companies, Gene Therapy, Science and Engineering, Drug Discovery, Aav, Genetics, Glybera, Health Care, Lpl, Medical, Hemophilia |
Keywords | Gene Editing, Genetic Testing |
Looking for a particular uniQure employee's phone or email?
Mathieu Streefland is the Vice President Global Process Development of uniQure.
612 people are employed at uniQure.
uniQure is based in Amsterdam, North Holland.